What happened in China Baidu Health launched 'Youyi Assistant,' a medical AI agent designed to support doctors with clinical research, documentation, and task execution at the point of care. The product has been positioned as China's first task-oriented AI assistant implemented in a medical setting, built on the OpenClaw framework — Baidu's own agentic infrastructure layer. The timing was not accidental. On 2 April 2026, China's National Medical Products Administration (NMPA) issued formal Implementing Opinions on 'Artificial Intelligence +' in healthcare, signalling that Beijing is moving from device-level approvals toward a policy architecture that actively encourages AI agents operating inside clinical workflows. This is a meaningful shift: the NMPA has already approved a total of 154 AI-based medical devices since its first approval in 2020, with annual approvals accelerating sharply from 9 in 2020 to 45 in 2024. The regulatory pipeline is not slowing down — it is being…